Treatment of Parkinson's disease.
Levodopa is widely regarded as the treatment of choice in Parkinson's disease although complications gradually emerge during long-term therapy. The addition of adjuvants may be worthwhile, but it must be recognized that drug therapy offers incomplete and diminished symptom relief.
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004876:Ergot Alkaloids / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000523:psychology / Q000628:therapy*; D010817:Physician-Patient Relations; D012944:Social Support; D013238:Stereotaxic Techniques
D000978:Antiparkinson Agents; D004876:Ergot Alkaloids; D010276:Parasympatholytics; D007980:Levodopa